Cargando…

Gene expression biomarkers of response to citalopram treatment in major depressive disorder

There is significant variability in antidepressant treatment outcome, with ∼30–40% of patients with major depressive disorder (MDD) not presenting with adequate response even following several trials. To identify potential biomarkers of response, we investigated peripheral gene expression patterns o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mamdani, F, Berlim, M T, Beaulieu, M-M, Labbe, A, Merette, C, Turecki, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309465/ https://www.ncbi.nlm.nih.gov/pubmed/22832429 http://dx.doi.org/10.1038/tp.2011.12

Ejemplares similares

Efficacy and safety of citalopram versus amitriptyline in the treatment of major depression
por: Mathur, Anand, et al.
Publicado: (2005)

Regional default mode network connectivity in major depressive disorder: modulation by acute intravenous citalopram
por: Dutta, Arpan, et al.
Publicado: (2019)

Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response
por: Fiori, Laura M, et al.
Publicado: (2017)

Serum N-Desmethylcitalopram Concentrations are Associated with the Clinical Response to Citalopram of Patients with Major Depression
por: Ozbey, Gul, et al.
Publicado: (2018)

Serotonin Transporter Polymorphism (5-HTTLPR) and Citalopram Effectiveness in Iranian Patients with Major Depressive Disorder
por: Sahraian, Shima, et al.
Publicado: (2013)

Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients
por: Bhattacharyya, Sudeepa, et al.
Publicado: (2019)

Double-Blind Randomized Clinical Trial of the Efficacy of Venlafaxine Versus Citalopram in the Treatment of the Acute Phase of Major Depressive Disorder
por: Hosseini, Fatemeh, et al.
Publicado: (2015)

Citalopram for major depressive disorder in adults: a systematic review and meta-analysis of published placebo-controlled trials
por: Apler, Alex
Publicado: (2011)

Citalopram and metacognitive therapy for depressive symptoms and cognitive emotion regulation in patients with major depressive disorder: A randomized controlled trial
por: Kheirabadi, Gholam Reza, et al.
Publicado: (2020)

Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression
por: MahmoudianDehkordi, Siamak, et al.
Publicado: (2021)

Balance Problems, Paralysis, and Angina as Clinical Markers for Severity in Major Depression
por: Qi, Bill, et al.
Publicado: (2020)

No association between the PREP gene and lithium responsive bipolar disorder
por: Mamdani, Firoza, et al.
Publicado: (2007)

Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial
por: Clayton, Anita H., et al.
Publicado: (2015)

Global Brain Gene Expression Analysis Links Glutamatergic and GABAergic Alterations to Suicide and Major Depression
por: Sequeira, Adolfo, et al.
Publicado: (2009)

Predictive Biomarkers of Treatment Response in Major Depressive Disorder
por: Stolz, Louise A., et al.
Publicado: (2023)

Identification of potential blood biomarkers associated with suicide in major depressive disorder
por: Mamdani, Firoza, et al.
Publicado: (2022)

The use of citalopram for the treatment of cataplexy()
por: Fonseca, Hassana de Almeida, et al.
Publicado: (2014)

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
por: Aldrich, Stacey L., et al.
Publicado: (2019)

Bridging Basic and Clinical Research in Early Life Adversity, DNA Methylation, and Major Depressive Disorder
por: Brown, Amanda, et al.
Publicado: (2019)

Comparing the Efficacy of 8 Weeks Treatment of Cipram® and its Generic Citalopram in Patients With Mixed Anxiety-Depressive Disorder
por: Khoonsari, Hasan, et al.
Publicado: (2015)

A review of citalopram dose restrictions in the treatment of neuropsychiatric disorders in older adults
por: McCarrell, Jamie L., et al.
Publicado: (2019)

Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients
por: Barakat, Abdul Karim, et al.
Publicado: (2020)

Escitalopram Versus Citalopram and Sertraline: A Double-Blind Controlled, Multi-centric Trial in Indian Patients with Unipolar Major Depression
por: Lalit, Vaya, et al.
Publicado: (2004)

Neuroimaging Biomarkers for Predicting Treatment Response and Recurrence of Major Depressive Disorder
por: Kang, Seung-Gul, et al.
Publicado: (2020)

Pharmacoeconomic evaluation of venlafaxine compared with citalopram in generalized anxiety disorder
por: ZHANG, JINGJING, et al.
Publicado: (2013)

Pharmacokinetic Genes Do Not Influence Response or Tolerance to Citalopram in the STAR*D Sample
por: Peters, Eric J., et al.
Publicado: (2008)

Meta-analysis of epigenome-wide association studies of major depressive disorder
por: Li, Qingqin S., et al.
Publicado: (2022)

Improving response inhibition systems in frontotemporal dementia with citalopram
por: Hughes, Laura E., et al.
Publicado: (2015)

Rise of escitalopram and the fall of citalopram
por: Cavanah, Luke R., et al.
Publicado: (2023)

DNA hypomethylation of Synapsin II CpG islands associates with increased gene expression in bipolar disorder and major depression
por: Cruceanu, Cristiana, et al.
Publicado: (2016)

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
por: Coleman, Jonathan A., et al.
Publicado: (2016)

Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder
por: Leuchter, Andrew F., et al.
Publicado: (2014)

Effect of citalopram and sertraline on the expression of miRNA- 124, 132, and 16 and their protein targets in patients with depression
por: Ahmadimanesh, Mahnaz, et al.
Publicado: (2023)

Effect of transcranial magnetic stimulation in combination with citalopram on patients with post-stroke depression
por: Zhu, Zhen, et al.
Publicado: (2022)

Machine Learning Analysis of Blood microRNA Data in Major Depression: A Case-Control Study for Biomarker Discovery
por: Qi, Bill, et al.
Publicado: (2020)

Citalopram intoxication in four week old infant
por: Janson, Jo-Anne, et al.
Publicado: (2020)

Effects of citalopram on heart rate variability in women with generalized anxiety disorder
por: Ranjbar, Fatemeh, et al.
Publicado: (2015)

Altered choroid plexus gene expression in major depressive disorder
por: Turner, Cortney A., et al.
Publicado: (2014)

Comparison of pramipexole and citalopram in the treatment of depression in Parkinson's disease: A randomized parallel-group trial
por: Ziaei, Ehsan, et al.
Publicado: (2022)

Baseline thyroid indices and the subsequent response to citalopram treatment, a pilot study
por: Abulseoud, Osama A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l3bdvhj29ctolh73va3mo9hjno